You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CPD

Take the Challenge: Assessing Knowledge and Practices in Food Allergy Diagnosis and Management

  • Authors: Hugh A. Sampson, MD
  • CPD Released: 3/3/2022
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 3/3/2023
Start Activity


Target Audience and Goal Statement

This activity is intended for an international audience of pediatricians, allergists and clinical immunologists, and emergency medicine physicians.

The goal of this activity is to assess clinicians' knowledge, attitudes, and competence regarding the clinical manifestations and management of food allergy, and their familiarity with the emerging treatment options for this condition.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Diagnosis and management of food allergy
    • Emerging therapies for food allergy
  • Self-assess learning needs related to
    • Diagnosis and management of food allergy


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.


Faculty

  • Hugh A. Sampson, MD

    Kurt Hirschhorn Professor of Pediatrics
    Emeritus Director; Jaffe Food Allergy Institute
    Department of Pediatrics
    Icahn School of Medicine at Mount Sinai
    New York, New York, United States

    Disclosures

    Advisor or consultant for: DBV Technologies; N-Fold, LLC; Siolta Therapeutics
    Stocks, stock options, or bonds from: DBV Technologies; N-Fold, LLC

Editors

  • Marinella Calle, PhD, CMPP

    Medical Education Director, WebMD Global, LLC 

    Disclosures

    Disclosure: Marinella Calle, PhD, CMPP, has disclosed no relevant financial relationships. 

  • Megan Breuer, PhD, CMPP

    Medical Writer, WebMD Global, LLC 

    Disclosures

    Disclosure: Megan Breuer, PhD, CMPP, has disclosed no relevant financial relationships. 

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance

    Disclosures

    Disclosure: Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.25 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Take the Challenge: Assessing Knowledge and Practices in Food Allergy Diagnosis and Management

Authors: Hugh A. Sampson, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CPD Released: 3/3/2022

Valid for credit through: 3/3/2023

processing....

References

  1. De Martinis M, et al. New perspectives in food allergy. Int J Mol Sci. 2020;21:1474.
  2. Gupta RS, et al. Prevalence and severity of food allergies among US adults. JAMA Netw Open. 2019;2:e185630.
  3. McGowan EC, et al. Prevalence of self-reported food allergy in the National Health and Nutrition Examination Survey (NHANES) 2007-2010. J Allergy Clin Immunol. 2013;132:1216-1219.
  4. American Academy of Allergy, Asthma, and Immunology (AAAAI). Food Intolerance Defined. Accessed 21 February 2022. https://www.aaaai.org/Tools-for-the-Public/Allergy,-Asthma-Immunology-Glossary/Food-Intolerance-Defined#:~:text=A%20food%20intolerance%2C%20or%20a,intolerances%20involve%20the%20digestive%20system
  5. Oriel RC, et al. Diagnosis and management of food allergy. Pediatr Clin North Am. 2019;66:941-954.
  6. Anvari S, et al. IgE-mediated food allergy. Clin Rev Allergy Immunol. 2019;57:244-260.
  7. NIAID-Sponsored Expert Panel, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126:S1-S8.
  8. Muraro A, et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014;69:1008-1025.
  9. Motosue MS, et al. National trends in emergency department visits and hospitalizations for food‐induced anaphylaxis in US children. Pediatr Allergy Immunol. 2018;29:538-544.
  10. Cader S. Case study: An approach to managing food allergies in a child. S Afr J Clin Nutr. 2017;30:52-57.
  11. NetCE Continuing Education. Course Case Studies: Food Allergies. Case Study 2. Accessed 21 February 2022. https://www.netce.com/casestudies.php?courseid=1790.
  12. Turnbull JL, et al. Review article: the diagnosis and management of food allergy and food intolerances. Aliment Pharmacol Ther. 2015;41:3-25.
  13. Halken S, et al. EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update). Pediatr Allergy Immunol. 2021;32:843-858.
  14. Sampson HA, et al. Food allergy: A practice parameter update-2014. J Allergy Clin Immunol. 2014;134:1016-1025.
  15. MacGinnitie AJ, et al. Omalizumab facilitates rapid oral desensitization for peanut allergy. J Allergy Clin Immunol. 2017;139:873-881.
  16. Kattan JD, et al. Optimizing the diagnosis of food allergy. Immunol Allergy Clin North Am. 2015;35:61-76.
  17. Gasser P, Tarchevskaya SS, Guntern P, et al. The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab. Nat Commun. 2020;11:165.
  18. Manti S, Pecora G, Patanè F, et al. Monoclonal Antibodies in Treating Food Allergy: A New Therapeutic Horizon. Nutrients. 2021;13:2314.
  19. Rial MJ, et al. Dupilumab for treatment of food allergy. J Allergy Clin Immunol Pract. 2019;7:673-674.
  20. Albuhairi S, et al. Novel therapies for treatment of food allergy. Immunol Allergy North Am. 2020;40:175-186.
  21. Schworer SA, et al. Sublingual immunotherapy for food allergy and its future directions. Immunotherapy. 2020;12:921-931.
  22. Kim JS, et al. Dietary baked milk accelerates the resolution of cow's milk allergy in children. J Allergy Clin Immunol. 2011;128:125-131.
« Return to: Take the Challenge: Assessing Knowledge and Practices in Food Allergy Diagnosis and Management
  • Print